Clinical Trial Update: Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sequential chemotherapy followed by blinatumomab in Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia to i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-negative B-cell Precursor Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Lymphoid Leukemia, Philadelphia Chromosome-Negative B-Cell Precursor | Phase 2 | Status: COMPLETED